ScholarIQanswers from OpenAlex & ORCID
Andrew Feigin
ResearcherPublications, citations & collaboration network
Andrew Feigin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrew Feigin have?
ScholarIQindexed works
Andrew Feigin has 158 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew Feigin have?
ScholarIQcitation count
Andrew Feigin has 11,167 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrew Feigin?
ScholarIQh-index
Andrew Feigin has an h-index of 54 in OpenAlex.
What is the i10-index of Andrew Feigin?
ScholarIQi10-index
Andrew Feigin has an i10-index of 92 in OpenAlex.
What is the OpenAlex record for Andrew Feigin?
ScholarIQopenalex
The OpenAlex for Andrew Feigin is on the source record.
What are the most-cited papers on Andrew Feigin?
ScholarIQmost cited works
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt, Andrew Feigin, Chengke Tang, Helen L. Fitzsimons, Paul J. Mattis, P. Lawlor, Ross Bland, Deborah Young, Kristin Strybing, David Eidelberg, Matthew J. During
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey, Steven Ojemann, Alice W. Flaherty, Emad N. Eskandar, Sandra K. Kostyk, Karen Thomas, Atom Sarkar, Mustafa Siddiqui, Stephen B. Tatter, Jason M. Schwalb, Kathleen L. Poston, Jaimie M. Henderson, Roger Kurlan, Irene Hegeman Richard, Lori Van Meter, Christine V. Sapan, Matthew J. During, Michael G. Kaplitt, Andrew Feigin
FDG PET in the differential diagnosis of parkinsonian disorders
Thomas Eckert, Anna Barnes, Vijay Dhawan, Steven J. Frucht, Mark Forrest Gordon, Andrew Feigin, David Eidelberg
Changes in network activity with the progression of Parkinson's disease
Chaorui Huang, Chengke Tang, Andrew Feigin, Martin Lesser, Yilong Ma, Michael Pourfar, Vijay Dhawan, David Eidelberg
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
Huntington Study Group, Samuel Frank, Claudia Testa, David Stamler, Elise Kayson, Charles S. Davis, Mary Edmondson, Shari Kinel, Blair R. Leavitt, David Oakes, Christine J. O’Neill, Christina Vaughan, Jody Goldstein, Margaret Herzog, Victoria Snively, Jacquelyn Whaley, Cynthia Wong, Greg Suter, Joseph Jankovic, Joohi Jimenez‐Shahed, Christine Hunter, Daniel O. Claassen, Olivia C. Roman, Victor Sung, Jenna Smith, Sarah Janicki, Ronda Clouse, Marie Saint‐Hilaire, Anna DePold Hohler, Denyse Turpin, Raymond James, Ramon L. Rodriguez, Kyle Rizer, Karen E. Anderson, Hope Heller, Alexis Carlson, Susan R. Criswell, Brad A. Racette, Fredy J. Revilla, Frederick C. Nucifora, Russell L. Margolis, MaryJane Ong, Tilak Mendis, Neila Mendis, Carlos Singer, Mónica Quesada, Jane S. Paulsen, Thomas Brashers-Krug, Amanda C. Miller, Jane Kerr, Richard Dubinsky, Carolyn Steele Gray, Stewart A. Factor, Elaine Sperin, Eric Molho, Mary Eglow, Sharon Evans, Rajeev Kumar, Christina Reeves, Ali Samii, Sylvain Chouinard, Monica Beland, B.L. Scott, Patrick Hickey, Sherali Esmail, Wai Lun Alan Fung, Clare Gibbons, Lina Qi, Amy Colcher, Cory Hackmyer, Andrew McGarry, Kevin J. Klos, Mark Gudesblatt, Lori Fafard, Laura Graffitti, Daniel Schneider, Rohit Dhall, Joanne Wojcieszek, Kathrin LaFaver, Andrew P. Duker, Erin Neefus, Hilary Wilson, David Shprecher, Paola Wall, Karen Blindauer, Lynn Wheeler, James T. Boyd, Emily Houston, Eric S. Farbman, Pinky Agarwal, Shirley Eberly, Arthur Watts, Pierre N. Tariot, Andrew Feigin, Scott Evans, Chris Beck, Constance Orme, Jon Edicola, Emily Christopher